Science | Nature | Cell | View More
Natural Products
Vemurafenib (PLX4032)
Vemurafenib (PLX4032)
ChemFaces products have been cited in many studies from excellent and top scientific journals
Product Name Vemurafenib (PLX4032)
Price:
CAS No.: 918504-65-1
Catalog No.: CFN60058
Molecular Formula: C23H18ClF2N3O3S
Molecular Weight: 489.92 g/mol
Purity: >=98%
Type of Compound: Alkaloids
Physical Desc.: Powder
Source:
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Download: COA    MSDS
Similar structural: Comparison
Guestbook:
Contact Us
Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC
How to Order
Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com
Delivery time
Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal
Citing Use of our Products
* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.
According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.
Size /Price /Stock 10 mM * 1 mL in DMSO / Inquiry
Other Packaging *Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap
Our products had been exported to the following research institutions and universities, And still growing.
  • Universiti Sains Malaysia (Malaysia)
  • Universiti Kebangsaan Malaysia (Malaysia)
  • Kamphaengphet Rajabhat University (Thailand)
  • University of Melbourne (Australia)
  • Center for protein Engineering ... (Belgium)
  • University of Wisconsin-Madison (USA)
  • National Cancer Institute (USA)
  • Periyar University (India)
  • Medizinische Universit?t Wien (Austria)
  • Seoul National University (Korea)
  • Medical University of Gdansk (Poland)
  • More...
Package
Featured Products
Parishin C

Catalog No: CFN93114
CAS No: 174972-80-6
Price: $238/20mg
4',5,6,7-Tetramethoxyflavone

Catalog No: CFN91034
CAS No: 1168-42-9
Price: $258/5mg
Rebaudioside C

Catalog No: CFN90258
CAS No: 63550-99-2
Price: $100/20mg
Indirubin

Catalog No: CFN90239
CAS No: 479-41-4
Price: $40/20mg
Epiberberine

Catalog No: CFN98564
CAS No: 6873-09-2
Price: $168/20mg
Fisetin

Catalog No: CFN98176
CAS No: 528-48-3
Price: $30/20mg
Schisandrol A

Catalog No: CFN99012
CAS No: 7432-28-2
Price: $30/20mg
Ginsenoside Rh4

Catalog No: CFN92594
CAS No: 174721-08-5
Price: $368/10mg
Neocryptotanshinone

Catalog No: CFN92181
CAS No: 109664-02-0
Price: $398/10mg
Punicalin

Catalog No: CFN98113
CAS No: 65995-64-4
Price: $218/20mg
Related Screening Libraries
Size /Price /Stock 10 mM * 100 uL in DMSO / Inquiry / In-stock
10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries
Biological Activity
Description: Vemurafenib (PLX4032, RG7204) is a novel and potent inhibitor of B-RafV600E with IC50 of 31 nM in cell-free assay. 10-fold selective for B-RafV600E over wild-type B-Raf in enzymatic assays and the cellular selectivity can exceed 100-fold. Vemurafenib (PLX4032, RG7204) induces autophagy.
Targets: B-RafV600E | Autophagy
In vitro:
Nature,2012 Jan 26;483(7387):100-3.
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.[Pubmed: 22281684]
Inhibition of the BRAF(V600E) oncoprotein by the small-molecule drug PLX4032 (vemurafenib) is highly effective in the treatment of melanoma. However, colon cancer patients harbouring the same BRAF(V600E) oncogenic lesion have poor prognosis and show only a very limited response to this drug.
METHODS AND RESULTS:
To investigate the cause of the limited therapeutic effect of PLX4032 in BRAF(V600E) mutant colon tumours, here we performed an RNA-interference-based genetic screen in human cells to search for kinases whose knockdown synergizes with BRAF(V600E) inhibition. We report that blockade of the epidermal growth factor receptor (EGFR) shows strong synergy with BRAF(V600E) inhibition. We find in multiple BRAF(V600E) mutant colon cancers that inhibition of EGFR by the antibody drug cetuximab or the small-molecule drugs gefitinib or erlotinib is strongly synergistic with BRAF(V600E) inhibition, both in vitro and in vivo. Mechanistically, we find that BRAF(V600E) inhibition causes a rapid feedback activation of EGFR, which supports continued proliferation in the presence of BRAF(V600E) inhibition. Melanoma cells express low levels of EGFR and are therefore not subject to this feedback activation. Consistent with this, we find that ectopic expression of EGFR in melanoma cells is sufficient to cause resistance to PLX4032.
CONCLUSIONS:
Our data suggest that BRAF(V600E) mutant colon cancers (approximately 8-10% of all colon cancers), for which there are currently no targeted treatment options available, might benefit from combination therapy consisting of BRAF and EGFR inhibitors.
Vemurafenib (PLX4032) Description
Source:
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Storage: Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

After receiving: The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
ChemFaces New Products and Compounds
Apterin

Catalog No: CFN95005
CAS No: 53947-89-0
Price: $388/10mg
Kakkalide

Catalog No: CFN95052
CAS No: 58274-56-9
Price: $260/10mg
Nomilinic acid

Catalog No: CFN95559
CAS No: 35930-20-2
Price: $318/5mg
Dehydrodicatechin A

Catalog No: CFN95451
CAS No: 36048-23-4
Price: $318/5mg
Henricine

Catalog No: CFN95244
CAS No: 107783-46-0
Price: $413/5mg
1,4-Dihydroxy-2-carbomethoxy-3-pre...

Catalog No: CFN95100
CAS No: 1415729-43-9
Price: $318/10mg
Clinopodic acid E

Catalog No: CFN95595
CAS No: 159736-38-6
Price: $318/5mg
Carasiphenol C

Catalog No: CFN95045
CAS No: 868168-04-1
Price: $368/5mg
Recently, ChemFaces products have been cited in many studies from excellent and top scientific journals

Cell. 2018 Jan 11;172(1-2):249-261.e12.
doi: 10.1016/j.cell.2017.12.019.
IF=36.216(2019)

PMID: 29328914

Cell Metab. 2020 Mar 3;31(3):534-548.e5.
doi: 10.1016/j.cmet.2020.01.002.
IF=22.415(2019)

PMID: 32004475

Mol Cell. 2017 Nov 16;68(4):673-685.e6.
doi: 10.1016/j.molcel.2017.10.022.
IF=14.548(2019)

PMID: 29149595

ACS Nano. 2018 Apr 24;12(4): 3385-3396.
doi: 10.1021/acsnano.7b08969.
IF=13.903(2019)

PMID: 29553709

Nature Plants. 2016 Dec 22;3: 16206.
doi: 10.1038/nplants.2016.205.
IF=13.297(2019)

PMID: 28005066

Sci Adv. 2018 Oct 24;4(10): eaat6994.
doi: 10.1126/sciadv.aat6994.
IF=12.804(2019)

PMID: 30417089
Calculate Dilution Ratios(Only for Reference)
1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.0411 mL 10.2057 mL 20.4115 mL 40.823 mL 51.0287 mL
5 mM 0.4082 mL 2.0411 mL 4.0823 mL 8.1646 mL 10.2057 mL
10 mM 0.2041 mL 1.0206 mL 2.0411 mL 4.0823 mL 5.1029 mL
50 mM 0.0408 mL 0.2041 mL 0.4082 mL 0.8165 mL 1.0206 mL
100 mM 0.0204 mL 0.1021 mL 0.2041 mL 0.4082 mL 0.5103 mL
* Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
Protocol
Kinase Assay:
Nature,2010 Sep 30;467(7315):596-9.
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma.[Pubmed: 20823850]
The kinase activities of wild-type RAF and mutants are determined by measuring phosphorylation of biotinylated-BAD protein. For each enzyme (0.01 ng), 20 μL reactions are carried out in 20 mM Hepes (pH 7.0), 10 mM MgCl2, 1 mM DTT, 0.01% (v/v) Tween-20, 50 nM biotin-BAD protein, and 1 mM ATP at room temperature. Reactions are stopped at 5 min with 5 μL of a solution containing 20 mM Hepes (pH 7.0), 200 mM NaCl, 80 mM EDTA, 0.3% (w/v) bovine serum albumin (BSA). The stop solution also includes phospho-BAD (Ser112) antibody, streptavidin-coated donor beads, and protein A acceptor beads. The antibody and beads are pre-incubated in stop solution in the dark at room temperature for 30 min. The final dilution of antibody is 1/2000 and the final concentration of each bead is 10 μg/mL. The assay plates are incubated at room temperature for one hour and then are read on a PerkinElmer AlphaQuest reader. Mutant activities are the average of two different batches of purified protein assayed in duplicate in three different experiments.
Cell Research:
Cancer Res,2010 Jul 1;70(13):5518-27.
RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models.[Pubmed: 20551065]
Cell lines:MALME-3M, Colo829, Colo38, A375, SK-MEL28, and A2058 cells
Concentrations: 0–10 μM , dissolved in DMSO
Incubation Time:  5 days
Method:
Cellular proliferation is evaluated by MTT assay. Briefly, cells are plated in 96-well microtiter plates at a density of 1000 to 5000 cells per well in a volume of 180 μL. PLX4032 is prepared at 10 times the final assay concentration in media containing 1% DMSO. Twenty-four hours after cell plating, 20 μL of the appropriate dilution of PLX4032 are added to plates in duplicate. The plates are assayed for proliferation 6 days after the cells are plated. Percent inhibition is calculated and the IC50 is determined from the regression of a plot of the logarithm of the concentration versus percent inhibition.
Animal Research:
Cancer Res, 2010 Jul 1;70(13):5518-27.
RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models.[Pubmed: 20551065]
Animal Models: Mice (athymic nude) xenograft models of LOX, Colo829, and A375 cells
Dosages:12.5 mg/kg–100 mg/kg
Administration: Oral gavage twice daily
Parishin C

Catalog No: CFN93114
CAS No: 174972-80-6
Price: $238/20mg
4',5,6,7-Tetramethoxyflavone

Catalog No: CFN91034
CAS No: 1168-42-9
Price: $258/5mg
Rebaudioside C

Catalog No: CFN90258
CAS No: 63550-99-2
Price: $100/20mg
Indirubin

Catalog No: CFN90239
CAS No: 479-41-4
Price: $40/20mg
Epiberberine

Catalog No: CFN98564
CAS No: 6873-09-2
Price: $168/20mg
Fisetin

Catalog No: CFN98176
CAS No: 528-48-3
Price: $30/20mg
Schisandrol A

Catalog No: CFN99012
CAS No: 7432-28-2
Price: $30/20mg
Ginsenoside Rh4

Catalog No: CFN92594
CAS No: 174721-08-5
Price: $368/10mg
Neocryptotanshinone

Catalog No: CFN92181
CAS No: 109664-02-0
Price: $398/10mg
Punicalin

Catalog No: CFN98113
CAS No: 65995-64-4
Price: $218/20mg
Tags: buy Vemurafenib (PLX4032) | Vemurafenib (PLX4032) supplier | purchase Vemurafenib (PLX4032) | Vemurafenib (PLX4032) cost | Vemurafenib (PLX4032) manufacturer | order Vemurafenib (PLX4032) | Vemurafenib (PLX4032) distributor